http www.abcam.com glutathione-s-transferase-mu-antibody-epr19362-ab108524.html Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression Cited in 10 publications Alterations in the glutathione and

truncatula including high quality reference genomes and gene annotations (Young et al., 2011

D., Slominski, A

For cryo-EM analysis, SLC33A1 MAP was solubilized in 2% lauryl maltose neopentyl glycol (Anatrace, NG310), 0.2% cholesteryl hemisuccinate Tris salt (Anatrace, CH210), 50LmM HEPES (pH-adjusted with KOH, pHL7.4), 150LmM KCl supplemented with protease-inhibitor cocktail (1LmM phenylmethylsulfonyl fluoride (PMSF), 2.5LmgLml 1 aprotinin, 2.5LmgLml 1 leupeptin, 1LmgLml 1 pepstatin A) and DNase I

Gut-derived immune activation exacerbates central pathology in stroke and in autoimmune diseases like MS, while there is evidence that dietary interventions and probiotics can also attenuate disease severity and improve functional outcome

Biochim Biophys Acta 2012;1823:143443

Protective effects of neurotrophic factor-secreting cells in a 6-OHDA Rat model of Parkinson disease